Impact of Haglund Syndrome on Ankle Mobility and Stability
Evaluation of Postural Stability and Ankle Mobility in Haglund Syndrome
This study is testing how Haglund syndrome affects ankle movement and balance in people with the condition compared to healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 25 Years to 56 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Minya) |
| Trial ID | NCT05905952 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effects of Haglund syndrome on ankle range of motion (ROM) and postural stability. It will involve fifty participants, including twenty-five patients diagnosed with symptomatic Haglund syndrome and twenty-five healthy volunteers matched for age, sex, and body mass index. The study will utilize the Biodex balance system to evaluate postural stability and an Electrogoniometer to measure ankle plantarflexion and dorsiflexion ROM. Participants will be aged between 25 and 56 years with a BMI of 18.5 to 24.9.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 25-56 with a diagnosis of Haglund syndrome and a BMI between 18.5 and 24.9.
Not a fit: Patients with other musculoskeletal disorders or cognitive and visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the relationship between Haglund syndrome and ankle mobility, potentially leading to improved management strategies for affected patients.
How similar studies have performed: While there may be limited studies specifically on Haglund syndrome, similar assessments of ankle mobility and stability have shown promising results in related conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * For patient group: * Patient referred from orthopedic surgeon with diagnoses as Haglund syndrome according to the following signs and symptoms * Calcaneal prominence diagnosed on lateral weight bearing radiograph with bony prominence superior to parallel pitch lines or posterior calcaneal angle greater than 75 degrees * Pain medially at insertion of tendo-achilles * Palpation of hard, bony prominence * Pain upon rising out of bed * Both unilateral and bilateral cases, and in consideration of dealing with bilateral cases the tested limb will be the most painful limb. * Age of 25-56 years * Both males and females. * BMI of (18.5 to 24.9) For control group: Healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs and will be included in the control group in this study . Exclusion Criteria: * Musculoskeletal disorders except Haglund syndrome * cognitive disorder, visual impairment that affected their daily living and any further medical condition that would prohibit them from participating safely in the chosen balance measures * sensory loss at foot or ankle and with a systemic inflammatory disease, such as diabetes mellitus, peripheral neuropathy, rheumatoid arthritis and ankylosing spondylitis, who had undergone corticosteroid injections or physical therapy in the last three months * Patients with vestibular or neurological disorders * Any other cause of posterior heel pain.
Where this trial is running
Minya
- Deraya University — Minya, Egypt (Recruiting)
Study contacts
- Principal investigator: enas F youssif, prof — Cairo University
- Study coordinator: nassif M mousa, Bachelor
- Email: nassif.magdy.moussa@gmail.com
- Phone: 01273152233
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.